Toxoplasmosis in females from Al-Anbar, Iraq

Background: Toxoplasmosis is a common zoonotic disease affecting one-third of the world population with potentially serious health implications. Aim of the study: To find the prevalence and risk factors of Toxoplasma gondii infection among females in Al-Anbar, Iraq.  Methodology: Over an eight-month period from (1st November 2021 to 30th June 2022), 200 females visiting private veterinary clinics in Al-Anbar (92 owned cats) participated in this prospective study. Age and residency were recorded. Blood samples were collected from all females and subjected first to the Toxoplasma Latex Agglutination test (TLAT). Samples of cat feces were collected from 57 (62%) pet and 35 (38%) stray cats and subjected first to direct microscopy looking for Toxoplasma oocysts. Blood and fecal samples were then tested by nested polymerase chain reaction (n-PCR) and real-time PCR. Results were then statistically analyzed. Results: Rates of human toxoplasmosis were (n=48, 24%), (n=60, 30%), and (n=77, 38.5%) with TLAT, n-PCR, and RT-PCR tests respectively. Likewise, rates of cat toxoplasmosis were (n=7, 7.6%), (n=55, 60%), and (n=80, 87.0%) with TLAT, n-PCR, and RT-PCR tests respectively.  Results of the latex test revealed that females >40 had a high rate of infection (45.8%) compared with those aged 31-40 years (33.8%) and those aged 21-30 years (13.0%) (P≤0.01). City resident females had a lower infection rate compared to village residents (29.7% vs. 55.4%). Conclusions: Toxoplasmosis was more prevalent in females >40 from rural areas but wasn’t related to contact with cats. Real-time PCR provided a better diagnostic yield. 

Toxoplasmosis in females from Al-Anbar, Iraq

Background: Toxoplasmosis is a common zoonotic disease affecting one-third of the world population with potentially serious health implications. Aim of the study: To find the prevalence and risk factors of Toxoplasma gondii infection among females in Al-Anbar, Iraq.  Methodology: Over an eight-month period from (1st November 2021 to 30th June 2022), 200 females visiting private veterinary clinics in Al-Anbar (92 owned cats) participated in this prospective study. Age and residency were recorded. Blood samples were collected from all females and subjected first to the Toxoplasma Latex Agglutination test (TLAT). Samples of cat feces were collected from 57 (62%) pet and 35 (38%) stray cats and subjected first to direct microscopy looking for Toxoplasma oocysts. Blood and fecal samples were then tested by nested polymerase chain reaction (n-PCR) and real-time PCR. Results were then statistically analyzed. Results: Rates of human toxoplasmosis were (n=48, 24%), (n=60, 30%), and (n=77, 38.5%) with TLAT, n-PCR, and RT-PCR tests respectively. Likewise, rates of cat toxoplasmosis were (n=7, 7.6%), (n=55, 60%), and (n=80, 87.0%) with TLAT, n-PCR, and RT-PCR tests respectively.  Results of the latex test revealed that females >40 had a high rate of infection (45.8%) compared with those aged 31-40 years (33.8%) and those aged 21-30 years (13.0%) (P≤0.01). City resident females had a lower infection rate compared to village residents (29.7% vs. 55.4%). Conclusions: Toxoplasmosis was more prevalent in females >40 from rural areas but wasn’t related to contact with cats. Real-time PCR provided a better diagnostic yield. 

Wavelets operational methods for fractional differential equations and systems of fractional differential equations

In this thesis, new and effective operational methods based on polynomials and wavelets for the solutions of FDEs and systems of FDEs are developed. In particular we study one of the important polynomial that belongs to the Appell family of polynomials, namely, Genocchi polynomial. This polynomial has certain great advantages based on which an effective and simple operational matrix of derivative was first derived and applied together with collocation method to solve some singular second order differential equations of Emden-Fowler type, a class of generalized Pantograph equations and Delay differential systems. A new operational matrix of fractional order derivative and integration based on this polynomial was also developed and used together with collocation method to solve FDEs, systems of FDEs and fractional order delay differential equations. Error bound for some of the considered problems is also shown and proved. Further, a wavelet bases based on Genocchi polynomials is also constructed, its operational matrix of fractional order derivative is derived and used for the solutions of FDEs and systems of FDEs. A novel approach for obtaining operational matrices of fractional derivative based on Legendre and Chebyshev wavelets is developed, where, the wavelets are first transformed into corresponding shifted polynomials and the transformation matrices are formed and used together with the polynomials operational matrices of fractional derivatives to obtain the wavelets operational matrix. These new operational matrices are used together with spectral Tau and collocation methods to solve FDEs and systems of FDEs

Phase formation of REBa2Cu3O7−δ (RE: Y0.5Gd0.5, Y0.5Nd0.5, Nd0.5Gd0.5) superconductors from nanopowders synthesised via co-precipitation

Phase formation of REBa2Cu3O7−δ (RE: Y0.5Gd0.5, Y0.5Nd0.5, Nd0.5Gd0.5) superconductors synthesised via co-precipitation (COP) method were investigated by thermogravimetric analysis (TGA), differential thermal analysis (DTA) and X-ray diffraction (XRD) analysis. All samples showed identical thermal decomposition behaviour from the thermogram in which 5 major weight losses were observed. However, XRD of the samples at different heat treatment temperatures showed different diffraction patterns indicating different thermolytic processes. Meanwhile, transmission electron microscopy and surface area analysis revealed that the powders obtained from COP have particle sizes ranging from 7 to 12 nm with relatively large surface area. Molar ratios of prepared samples obtained were near to the theoretical values as confirmed by elemental analyses using X-ray fluorescence (XRF). The TC(R=0) for sintered YGd, YNd and NdGd were 87 K, 86 K and 90 K, respectively. Surface morphological study via scanning electron microscope showed the structures of samples were dense and non porous

Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naïve and previously infected individuals.

Two mRNA vaccines, Pfizer-BNT162b2 and Moderna-mRNA-1273, obtained the Emergency Use Listing by WHO for preventing COVID-19. However, little is known about the difference in antibody responses induced by these two mRNA vaccines in naïve and previously infected (PI) individuals. We investigated the levels of anti-S-RBD (total, IgG and IgA) levels in naïve and PI individuals, 1-13 (median = 6) weeks following the second dose of either vaccine. Results in the naïve-vaccinated group, the mRNA-1273 vaccine induced significantly higher levels of anti-S-RBD total antibodies (3.5-fold; P < 0.001), IgG (2-fold, P < 0.01) and IgA (2.1-fold, P < 0.001) as compared with the BNT162b2 vaccine. In addition, both vaccines produced significantly higher anti-S-RBD total antibody levels in the PI-group compared with naïve-vaccinated group. The PI group elicited a higher level of anti-S-RBD IgG than the naïve-BNT162b2 (P = 0.05), but not more than the naïve-mRNA-1273 (P = 0.9) group. Interestingly, the PI vaccinated group elicited a comparable level of IgA ratio to the naïve-mRNA-1273 group but significantly higher than the naïve-BNT162b2 group (1.6-fold, P < 0.001). Our results showed that the PI-vaccinated group produces a higher level of antibodies than the naïve vaccinated group, particularly for those vaccinated with BNT162b2

Assessment of Sewage Molecular Markers in Port Dickson Coast and Kim Kim River with Sediment Linear Alkylbenzenes

The present study aimed to determine linear alkylbenzenes (LABs) concentrations as organic molecular marker for sewage pollution in the sediment samples collected from Coast of Port Dickson and Kim Kim River, Peninsular Malaysia. The adverse effects of anthropogenic inputs into the rivers and coastal environment could be detected by molecular organic markers such as LABs. The sediments were processed; their sources were identified and tested by gas chromatography-mass spectrometry (GC-MS). The significance of the differences among sampling stations for LAB concentrations and distribution at p < 0.05 was performed by analysis of variance and Post Hoc Tests, LSD procedures (ANOVA) and Pearson correlation coefficient. LABs indices which include internal to external (I/E) congeners, long to short chains L/S and homologs C13/C12 were used to identify the sewage treatment and degradation levels. Results of this study are statistically uncovered that the range of RLABs concentration in the investigated locations was between 112.0; 88.3 and 256.0; 119.0 ng�g1 dw, respectively. There was significant difference (p < 0.05) of LAB homologs with high percentage of C13-LAB homologs along sampling locations. The calculated LAB ratios (I/E) were within the range between 2.0; 1.7 and 4.1, 2.0, demonstrated that, the treated effluents from primary and secondary sources were discharged to the study areas. The degradation of LABs was 40–64% and 34–38% in the studied locations. The findings of this study suggested the powerfully indicators of LABs in tracing anthropogenic sewage contamination and the necessity of continuing wastewater treatment system improvemen

One Parameter Composite Semigroups of Linear Bounded Operators in Strong Operator Topology of Schatten Class Cp

For semigroups of linear bounded operators on Hilbert spaces, the problem of being in Cp , 0 Keyword

Are commercial antibody assays substantially underestimating SARS-CoV-2 ever infection? An analysis on a population-based sample in a high exposure setting

AbstractBackgroundPerformance of three automated commercial serological IgG-based assays was investigated for assessing SARS-CoV-2 ever (past or current) infection in a population-based sample in a high exposure setting.MethodsPCR and serological testing was performed on 394 individuals.ResultsSARS-CoV-2-IgG seroprevalence was 42.9% (95% CI 38.1%-47.8%), 40.6% (95% CI 35.9%-45.5%), and 42.4% (95% CI 37.6%-47.3%) using the CL-900i, VidasIII, and Elecsys assays, respectively. Between the three assays, overall, positive, and negative percent agreements ranged between 93.2%-95.7%, 89.3%-92.8%, and 93.8%-97.8%, respectively; Cohen kappa statistic ranged from 0.86-0.91; and 35 specimens (8.9%) showed discordant results. Among all individuals, 12.5% (95% CI 9.6%-16.1%) had current infection, as assessed by PCR. Of these, only 34.7% (95% CI 22.9%-48.7%) were seropositive by at least one assay. A total of 216 individuals (54.8%; 95% CI 49.9%-59.7%) had evidence of ever infection using antibody testing and/or PCR during or prior to this study. Of these, only 78.2%, 74.1%, and 77.3% were seropositive in the CL-900i, VidasIII, and Elecsys assays, respectively.ConclusionsAll three assays had comparable performance and excellent agreement, but missed at least 20% of individuals with past or current infection. Commercial antibody assays can substantially underestimate ever infection, more so when infection rates are high.</jats:sec

The global burden of adolescent and young adult cancer in 2019 : a systematic analysis for the Global Burden of Disease Study 2019

Background In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15-39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15-39 years to define adolescents and young adults. Findings There were 1.19 million (95% UI 1.11-1.28) incident cancer cases and 396 000 (370 000-425 000) deaths due to cancer among people aged 15-39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59.6 [54.5-65.7] per 100 000 person-years) and high-middle SDI countries (53.2 [48.8-57.9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14.2 [12.9-15.6] per 100 000 person-years) and middle SDI (13.6 [12.6-14.8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23.5 million (21.9-25.2) DALYs to the global burden of disease, of which 2.7% (1.9-3.6) came from YLDs and 97.3% (96.4-98.1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe

The global burden of cancer attributable to risk factors, 2010-19 : a systematic analysis for the Global Burden of Disease Study 2019

Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe